Toxicity and outcomes in combined modality treatment of head and neck squamous cell carcinoma: cisplatin versus cetuximab.
about
Selective apoptotic cell death effects of oral cancer cells treated with destruxin BDeguelin induces apoptosis by targeting both EGFR-Akt and IGF1R-Akt pathways in head and neck squamous cell cancer cell lines.The rationale for HPV-related oropharyngeal cancer de-escalation treatment strategiesSurvival, recurrence and toxicity of HNSCC in comparison of a radiotherapy combination with cisplatin versus cetuximab: a meta-analysisTransoral Robotic Surgery in the HPV Era.Re-irradiation with cetuximab or cisplatin-based chemotherapy for recurrent squamous cell carcinoma of the head and neck.Survival outcomes based on systemic agent used concurrently with radiation in human-papillomavirus associated oropharyngeal cancer.A comparison of concurrent cisplatin versus cetuximab with radiotherapy in locally-advanced head and neck cancer: A bi-institutional analysis.Investigation of p16 status, chemotherapy regimen, and other nutrition markers for predicting gastrostomy in patients with head and neck cancer.
P2860
Q33903806-1AEFBA31-39D1-4BAC-984A-63B4B9D085DAQ35667885-3918EA61-C4C7-43E9-9CD4-B79214F31377Q35838231-E9A4176B-0917-45B7-8B03-E5B6EFE1CD04Q36114633-4EEFEEAA-B355-4642-8515-1393214F6099Q38210212-2881E0C9-C23A-41A1-94B9-0D5859819200Q39003223-AE416095-A53D-43F6-8EAC-0AE509F7D1B0Q42378492-E2B8EA39-4B92-40BE-98E5-92FD4E8A5D29Q52759019-B276DD7A-3F44-403B-BDC1-4187707C529AQ52902619-26A149C4-E562-4AD5-9DA5-2B020E9E2793
P2860
Toxicity and outcomes in combined modality treatment of head and neck squamous cell carcinoma: cisplatin versus cetuximab.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Toxicity and outcomes in combi ...... a: cisplatin versus cetuximab.
@en
Toxicity and outcomes in combi ...... a: cisplatin versus cetuximab.
@nl
type
label
Toxicity and outcomes in combi ...... a: cisplatin versus cetuximab.
@en
Toxicity and outcomes in combi ...... a: cisplatin versus cetuximab.
@nl
prefLabel
Toxicity and outcomes in combi ...... a: cisplatin versus cetuximab.
@en
Toxicity and outcomes in combi ...... a: cisplatin versus cetuximab.
@nl
P2093
P356
P1476
Toxicity and outcomes in combi ...... a: cisplatin versus cetuximab.
@en
P2093
Allison Y Ye
Cheryl C Ho
Janessa J Laskin
John H Hay
P304
P356
10.4103/0973-1482.126455
P407
P577
2013-10-01T00:00:00Z